Validation of a Quantitative Determination Method for Ormustine in a Lyophilized Dosage Form
- Autores: Bunyatyan N.D.1,2, Nikolaeva L.L.1,3, Olefir Y.V.2, Sanarova E.V.3, Oborotova N.A.1,2, Prokof’ev A.B.1,2, Ignat’eva E.V.3, Yartseva I.V.3, Gulyakin I.D.3
-
Afiliações:
- I. M. Sechenov First Moscow State Medical University (Sechenov University)
- Scientific Centre for Expert Evaluation of Medicinal Products, Ministry of Health of the Russian Federation
- N. N. Blokhin Russian Oncological Research Center, Russian Academy of Medical Sciences
- Edição: Volume 51, Nº 11 (2018)
- Páginas: 1037-1040
- Seção: Article
- URL: https://ogarev-online.ru/0091-150X/article/view/244899
- DOI: https://doi.org/10.1007/s11094-018-1735-3
- ID: 244899
Citar
Resumo
Validation results for a spectrophotometric quantitative determination method for ormustine in a lyophilized dosage form are presented. The method is shown to be suitable for quantitative determination of ormustine with respect to parameters such as specificity, linearity, accuracy, repeatability, and intermediate precision.
Palavras-chave
Sobre autores
N. Bunyatyan
I. M. Sechenov First Moscow State Medical University (Sechenov University); Scientific Centre for Expert Evaluation of Medicinal Products, Ministry of Health of the Russian Federation
Autor responsável pela correspondência
Email: ndbun@mail.ru
Rússia, Moscow, 119991; Moscow, 127051
L. Nikolaeva
I. M. Sechenov First Moscow State Medical University (Sechenov University); N. N. Blokhin Russian Oncological Research Center, Russian Academy of Medical Sciences
Email: ndbun@mail.ru
Rússia, Moscow, 119991; Moscow, 115478
Yu. Olefir
Scientific Centre for Expert Evaluation of Medicinal Products, Ministry of Health of the Russian Federation
Email: ndbun@mail.ru
Rússia, Moscow, 127051
E. Sanarova
N. N. Blokhin Russian Oncological Research Center, Russian Academy of Medical Sciences
Email: ndbun@mail.ru
Rússia, Moscow, 115478
N. Oborotova
I. M. Sechenov First Moscow State Medical University (Sechenov University); Scientific Centre for Expert Evaluation of Medicinal Products, Ministry of Health of the Russian Federation
Email: ndbun@mail.ru
Rússia, Moscow, 119991; Moscow, 127051
A. Prokof’ev
I. M. Sechenov First Moscow State Medical University (Sechenov University); Scientific Centre for Expert Evaluation of Medicinal Products, Ministry of Health of the Russian Federation
Email: ndbun@mail.ru
Rússia, Moscow, 119991; Moscow, 127051
E. Ignat’eva
N. N. Blokhin Russian Oncological Research Center, Russian Academy of Medical Sciences
Email: ndbun@mail.ru
Rússia, Moscow, 115478
I. Yartseva
N. N. Blokhin Russian Oncological Research Center, Russian Academy of Medical Sciences
Email: ndbun@mail.ru
Rússia, Moscow, 115478
I. Gulyakin
N. N. Blokhin Russian Oncological Research Center, Russian Academy of Medical Sciences
Email: ndbun@mail.ru
Rússia, Moscow, 115478
Arquivos suplementares
